Pediatric high-grade gliomas: survival at what cost?

Survival of children with tumors of the central nervous system has improved over the past three decades with more than 70% of patients now expected to survive at least five years (1). However, pediatric CNS tumors are histologically heterogeneous, affect children over a wide span of developmental stages, and have vastly different treatment approaches.